Drugs / ABT-614
last change Apr 2012 re-read 3 minutes ago

ABT-614

Developed for
diabetic kidney disease
Investigated by
Abbott

Trials 3

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01464320 Nov 2011 → Apr 2012 diabetic kidney disease Abbott Completed No outcome recorded
Phase 1 NCT00959816 Aug 2009 — Abbott Completed No outcome recorded
Phase 1 NCT00788801 Dec 2008 → Mar 2009 — Abbott Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as ABT-614 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01464320 ↗
2

NCT00959816 ↗

NCT00788801 ↗